These data revealed a novel miR-200c/NPC1 regulatory axis in breast cancer that may contribute to the differences in patient tumors observed in publicly available datasets, and suggest basal NPC1 upregulation as a unique feature in these tumor cells. This evidence concerns the gene NPC1 and neoplasm.